Platelet factor 4(PF4) and its multiple roles in diseases.

Area of Science:

• Immunology
• Hematology
• Pharmacology

Background:

• Platelet factor 4 (PF4) is a chemokine involved in immune responses.
• PF4-heparin complexes can trigger IgG antibodies, leading to heparin-induced thrombocytopenia (HIT).
• PF4's role in COVID-19 vaccine-induced immune thrombotic thrombocytopenia (VITT) highlights its broader clinical significance.

Purpose of the Study:

• To review the characteristics and biological functions of PF4.
• To summarize PF4-mediated signaling pathways.
• To discuss PF4's diverse roles in various diseases.

Main Methods:

• Literature review of PF4's involvement in thrombosis and other conditions.
• Analysis of PF4's electrostatic interactions with charged molecules.
• Exploration of PF4's signaling pathways and pharmacological effects.

Main Results:

• PF4 plays a critical role in both HIT and VITT, involving electrostatic interactions.
• Emerging evidence indicates PF4's involvement in hematopoietic inhibition, angiogenesis, coagulation, inflammation, and antitumor activity.
• PF4 exhibits pleiotropic properties, presenting challenges for targeted drug development.

Conclusions:

• PF4's multifaceted roles necessitate further research into its mechanisms.
• Understanding PF4 pathways can accelerate the development of targeted therapies for PF4-related diseases.
• Clinical translation of PF4-targeted therapies requires addressing current developmental challenges.